Literature DB >> 15941844

Reduction in plasma free fatty acid in patients with chronic obstructive pulmonary disease.

Hiroo Wada, Hajime Goto, Erika Saitoh, Ryuji Ieki, Tatsuru Okamura, Tomohiro Ota, Shin-Ichi Hagiwara, Takaharu Kodaka, Yorihiro Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15941844     DOI： 10.1164/ajrccm.171.12.950

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis?

Authors:  Gregory A Hawkins; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

Review 2.  Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

Review 3.  Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov; Aleksei Bulgakov
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

4.  Serum Acylglycerols Inversely Associate with Muscle Oxidative Capacity in Severe COPD.

Authors:  Rongsong Li; Alessandra Adami; Chih-Chiang Chang; Chi-Hong Tseng; Tzung K Hsiai; Harry B Rossiter
Journal:  Med Sci Sports Exerc       Date:  2021-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.